PMC:7647877 / 77712-77905 JSONTXT

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T319","span":{"begin":139,"end":149},"obj":"Disease"},{"id":"T320","span":{"begin":176,"end":184},"obj":"Disease"}],"attributes":[{"id":"A319","pred":"mondo_id","subj":"T319","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"},{"id":"A320","pred":"mondo_id","subj":"T320","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"Finally, we can conclude that personalized immunonutrition for obese patients should be the first therapeutic choice to reduce the risk of infections and the disease course in COVID-19 patient."}

{"project":"LitCovid-sentences","denotations":[{"id":"T481","span":{"begin":0,"end":193},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Finally, we can conclude that personalized immunonutrition for obese patients should be the first therapeutic choice to reduce the risk of infections and the disease course in COVID-19 patient."}

{"project":"LitCovid-PubTator","denotations":[{"id":"1710","span":{"begin":69,"end":77},"obj":"Species"},{"id":"1711","span":{"begin":185,"end":192},"obj":"Species"},{"id":"1713","span":{"begin":63,"end":68},"obj":"Disease"},{"id":"1714","span":{"begin":139,"end":149},"obj":"Disease"},{"id":"1715","span":{"begin":176,"end":184},"obj":"Disease"}],"attributes":[{"id":"A1710","pred":"tao:has_database_id","subj":"1710","obj":"Tax:9606"},{"id":"A1711","pred":"tao:has_database_id","subj":"1711","obj":"Tax:9606"},{"id":"A1713","pred":"tao:has_database_id","subj":"1713","obj":"MESH:D009765"},{"id":"A1714","pred":"tao:has_database_id","subj":"1714","obj":"MESH:D007239"},{"id":"A1715","pred":"tao:has_database_id","subj":"1715","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Finally, we can conclude that personalized immunonutrition for obese patients should be the first therapeutic choice to reduce the risk of infections and the disease course in COVID-19 patient."}